Skip to main content

Table 4 Stability (%) of liraglutide in the rat plasma and brain tissue under four different conditions (mean ± SD, = 3)

From: Pharmacokinetics and brain distribution of the therapeutic peptide liraglutide by a novel LC–MS/MS analysis

Matrix

Concentration (ng/mL)

Short-term stability (%)

Long-term stability (%)

Autosampler stability (%)

Freeze/thaw stability (%)

Plasma

800

103.93 ± 2.51

104.84 ± 3.03

100.00 ± 3.39

100.98 ± 0.67

80

109.73 ± 4.77

106.74 ± 1.75

109.32 ± 2.14

103.62 ± 2.39

4

107.91 ± 8.80

111.61 ± 2.09

96.93 ± 2.54

102.14 ± 9.85

Brain

160

100.63 ± 1.45

103.64 ± 4.21

104.64 ± 3.02

103.07 ± 6.51

40

96.44 ± 1.96

95.28 ± 6.60

92.24 ± 8.69

86.60 ± 2.99

8

109.38 ± 9.94

90.42 ± 9.70

87.46 ± 11.79

92.85 ± 12.34

  1. Short-term, 4 h at room temperature; long-term, 7 days at − 70 °C; autosampler, 24 h in the autosampler; freeze/thaw, 3 freeze/thaw cycles